SynthesisThe international journal of neuropsychopharmacology2017

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients.

Lídia Blanco-Silvente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.